• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Randomized head-to-head comparison of pitavastatin, atorvastatin, and rosuvastatin for safety and efficacy (quantity and quality of LDL): -- the PATROL trial].

作者信息

Saku Keijiro, Zhang Bo, Noda Keita

机构信息

Department of Cardiology, Fukuoka University School of Medicine, Japan.

出版信息

Nihon Naika Gakkai Zasshi. 2011 Dec 10;100(12):3679-86. doi: 10.2169/naika.100.3679.

DOI:10.2169/naika.100.3679
PMID:22338904
Abstract
摘要

相似文献

1
[Randomized head-to-head comparison of pitavastatin, atorvastatin, and rosuvastatin for safety and efficacy (quantity and quality of LDL): -- the PATROL trial].匹伐他汀、阿托伐他汀和瑞舒伐他汀安全性及疗效的随机头对头比较（低密度脂蛋白的量与质）：——PATROL试验
Nihon Naika Gakkai Zasshi. 2011 Dec 10;100(12):3679-86. doi: 10.2169/naika.100.3679.
2
Randomized head-to-head comparison of pitavastatin, atorvastatin, and rosuvastatin for safety and efficacy (quantity and quality of LDL): the PATROL trial.随机头对头比较匹伐他汀、阿托伐他汀和瑞舒伐他汀的安全性和疗效（LDL 的数量和质量）：PATROL 试验。
Circ J. 2011;75(6):1493-505. doi: 10.1253/circj.cj-10-1281. Epub 2011 Apr 15.
3
Strong statins as the major players for dyslipidemia in high-risk patients: are they all the same or not?强效他汀类药物作为高危患者血脂异常的主要治疗药物：它们是否都一样？
Circ J. 2011;75(6):1326-7. doi: 10.1253/circj.cj-11-0410. Epub 2011 Apr 29.
4
Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.瑞舒伐他汀10毫克/天与阿托伐他汀10毫克/天对高危成年人影响的12周多中心随机开放标签比较：一项探索性研究
Clin Ther. 2004 Nov;26(11):1821-33. doi: 10.1016/j.clinthera.2004.11.015.
5
Comparison of rosuvastatin versus atorvastatin in South-Asian patients at risk of coronary heart disease (from the IRIS Trial).瑞舒伐他汀与阿托伐他汀对南亚冠心病高危患者的比较（来自IRIS试验）
Am J Cardiol. 2007 Jun 1;99(11):1538-43. doi: 10.1016/j.amjcard.2007.01.028. Epub 2007 Apr 16.
6
Comparison of benefits and risks of rosuvastatin versus atorvastatin from a meta-analysis of head-to-head randomized controlled trials.瑞舒伐他汀与阿托伐他汀利弊比较：来自头对头随机对照试验的荟萃分析
Am J Cardiol. 2008 Dec 15;102(12):1654-62. doi: 10.1016/j.amjcard.2008.08.014. Epub 2008 Sep 20.
7
Efficacy and safety of rosuvastatin and atorvastatin in patients with hypercholesterolemia and a high risk of coronary heart disease: a randomized, controlled trial.瑞舒伐他汀与阿托伐他汀治疗高胆固醇血症合并冠心病高危患者的疗效及安全性：一项随机对照试验
Am Heart J. 2004 Jul;148(1):e4. doi: 10.1016/j.ahj.2004.01.020.
8
Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial).瑞舒伐他汀与阿托伐他汀、辛伐他汀和普伐他汀不同剂量疗效及安全性的比较（STELLAR*试验）
Am J Cardiol. 2003 Jul 15;92(2):152-60. doi: 10.1016/s0002-9149(03)00530-7.
9
More Western hypercholesterolemic patients achieve Japan Atherosclerosis Society LDL-C goals with rosuvastatin therapy than with atorvastatin, pravastatin, or simvastatin therapy.与阿托伐他汀、普伐他汀或辛伐他汀治疗相比，更多西方高胆固醇血症患者使用瑞舒伐他汀治疗可达到日本动脉粥样硬化协会的低密度脂蛋白胆固醇（LDL-C）目标。
Circ J. 2004 Feb;68(2):107-13. doi: 10.1253/circj.68.107.
10
Is rosuvastatin really a more efficient therapeutic option than atorvastatin?瑞舒伐他汀真的是比阿托伐他汀更有效的治疗选择吗？
Value Health. 2006 Jul-Aug;9(4):276-7; author reply 277-9. doi: 10.1111/j.1524-4733.2006.00111.x.

引用本文的文献

1
Comparative Lipid-Lowering/Increasing Efficacy of 7 Statins in Patients with Dyslipidemia, Cardiovascular Diseases, or Diabetes Mellitus: Systematic Review and Network Meta-Analyses of 50 Randomized Controlled Trials.比较 7 种他汀类药物在血脂异常、心血管疾病或糖尿病患者中的降脂/增脂疗效：50 项随机对照试验的系统评价和网络荟萃分析。
Cardiovasc Ther. 2020 Apr 23;2020:3987065. doi: 10.1155/2020/3987065. eCollection 2020.